Category - Drug discovery

Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML)

Project aims to standardize MRD data generation, assessment and accelerate AML clinical trial programs bringing novel therapies to patients in need faster SAN FRANCISCO, Jan. 14, 2021 /PRNewswire/ — Invitae...read more

QIAGEN Announces Global Distribution Agreement for the COSMIC Database from the Wellcome Sanger Institute

Exclusive sales, marketing, support and distribution by QIAGEN Including over 71 million cancer mutations, the COSMIC Database joins QIAGENs’ portfolio for cancer genomic analysis and interpretation Agreement effective...read more

2020 Was Not Just About COVID-19

Certainly, the coronavirus and, with that COVID-19, has dominated 2020 and massively impacted not only our daily lives, but also the medical health care community and healthcare facilities in particular. Genomics proved...read more

Mission Bio Raises $70M in Series C Funding Led by Novo Holdings to Accelerate Development of Cancer Therapies with Single-cell Multi-omics

Merck’s Research Laboratory President Dr. Roger Perlmutter Shares His Vision on “How Personalized Medicine Will Impact Healthcare”

At Bio-IT 2015 Big Data via Integration Platforms for Data Analysis, Patient Monitoring, and Collaboration

%d bloggers like this:

Category - Drug discovery

Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML)

QIAGEN Announces Global Distribution Agreement for the COSMIC Database from the Wellcome Sanger Institute

Mission Bio Raises $70M in Series C Funding Led by Novo Holdings to Accelerate Development of Cancer Therapies with Single-cell Multi-omics

Atomwise Raises $123 Million in Series B Financing Co-Led by B Capital Group and Sanabil

Genuity Science Announces Strategic Collaboration with Nashville Biosciences

Genomics England launches next-generation research platform central to UK COVID-19 response

WuXi NextCODE Restructures and Becomes Genuity Science

Archived news – SARS-CoV-2 vaccine development

Regeneron And Colorado Center For Personalized Medicine Announce Major New Human Genetics Research Collaboration

COVID-19 / SARS-CoV-2

Monthly Industry News

This year’s Bio-IT 2016 With Clinical Genetics as the Frontrunner

Merck’s Research Laboratory President Dr. Roger Perlmutter Shares His Vision on “How Personalized Medicine Will Impact Healthcare”

Follow Me

Most popular

Quest Diagnostics Granted CDC Contract to Sequence COVID-19 Gene Variants to Aid Public Health Response to COVID-19

Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML)

Pacific Biosciences and Invitae to Develop Ultra-High-Throughput Clinical Whole Genome Sequencing Platform

Personal Genome Diagnostics and QIAGEN Collaborate to Offer Integrated Genomic Testing and Interpretation Support

The Promise and Hope of RNA-based vaccines for COVID-19

Delfi Diagnostics Announces $100 Million Series A Financing to Develop a New Class of Early Detection Liquid Biopsy for Multiple Cancers

NuProbe Closes $42M Fundraising

Helix® Laboratory Platform Granted the First and Only FDA Authorization for a Whole Exome Sequencing Platform

QIAGEN Announces Global Distribution Agreement for the COSMIC Database from the Wellcome Sanger Institute

Pharmacogenetic and Genealogy Pioneers Merge for Historic Partnership

Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance Infrastructure

Most discussed

Genohm Aims to Hit the Sweet Spot With a Customizable SLIMS + ELN Solution for Lab Information Management

Just Released – Our New Clinical NGS Process Report

Genomenon’s Automated Genomic Search Engine Mastermind Illuminates Current Trends in Genomic Literature – A Look at the Top Cited Variants Across the Scientific Literature

The JP Morgan Healthcare Conference from Afar

Immunotherapy and the Basis of Neoantigen Biology: Part I Neoantigens

Nebula Genomics’ Goal Is To Make The Value of Genome Sequencing a Reality

The Life of a Genetic Counselor: Providing Patient Education, Navigating Insurance, and Challenges in Choosing Tests

Review of Emerging 2018 Genomic Variants – a Genomenon Research Report

PMWC 2016 Silicon Valley: Scalable Clinical Data Interpretation The Biggest Bottleneck